My take is that the NYT article is being spun by the
My take is that the NYT article is being spun by the criminal soft bashers as a very feeble false narrative. Take a step back and put yourself in the current administration’s shoes. Do you put all of your eggs in the vaccine basket that won’t be available until 2021 AFTER the election or do you fast track a treatment that basically kills the virus on contact? This treatment could be approved BEFORE the election to make CV19 considerably less threatening and allowing people to feel comfortable going to restaurants, airplanes, school etc.. basically getting back to normalcy and getting the economy back on track. Also note from the article:
“But the shift in strategy also shows that the administration is backing away from the relatively modest funding it has provided so far for treatments that address the severe lung ailments, while CONTINUING support for ANTIVIRAL therapies that could treat people earlier in the course of the disease.”
Wednesday’s 95% to 97% inhibition on human lung testing sets a new bar for antiviral therapies. The current best hope is Remdesivir which reduces hospital stays from 14 to 11 days. If Brilacidin is HALF as effective in human FDA trials as it is in the labs it will be by far the most effective and safe treatment. Based on Brilacidin’s multiple Phase 2 successes especially with ABSSSI, my bet is that human trials are a huge success. The antiviral, immuno/ anti-inflammatory and antimicrobial properties will make Brilacidin the top CV19 treatment.
Trying to negatively spin the NYT article is really grasping at straws but the criminals are between a rock and a hard place and they keep digging themselves a bigger hole. They have to somehow convince Longs to sell them shares. It will get progressively more challenging for them to maintain control over SP. It is going to be fun watching them lose control when grant funding and human FDA trials are announced. Hopefully they pay more than just a financial loss. IMO the squeeze won’t take place in a big way until $5 +/share. If they tried covering their 60-200M naked shares sub-dollar, the supply/demand imbalance would skyrocket SP. The criminals are in a pay me now or pay me later box.
12
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
An Unpredicted Victory in Samarkand Well, color me surprised. Timur Turlov's made waves by clinching the role of FIDE President at the General Assembly in Samarkand. This one's quite the turn for the chess world—Kazakhstan’s own stepping up to run the whole show. This isn't just some ceremonial post either. Turlov, who's been pulling strings over at the Kazakhstan...
Continue Reading
Shining a Light on Essential Family Farmers Every year, thousands gather for Farm Aid to back the unsung heroes who put food on our plates. In 2026, the scene shifted to the amphitheater at Virginia Beach, where an epic lineup of music took stage not just to entertain but to underline a critical issue—family farmers are fighting for survival. These folks aren't merely...
Continue Reading
Unseen Perils of Winter Heating in Massachusetts Massachusetts homeowners, listen up. If your heating system is older than the Model T, it's time to rethink your winter strategy. You don't want to be stuck in the cold when the thermometer hits single digits, do you? That's where Townsend comes in, making waves with their rebate assistance program. Navigating the Rebate...
Continue Reading
University's Innovative Approach to Learning Alright, here's something you don't see every day. The University of Phoenix managed to snag some kudos from an academic journal for using AI and storytelling to teach environmental science. That's like hitting two bulls-eyes with one shot in the world of education. The recognition from Glacies for this Editor's Choice paper...
Continue Reading
Modular Solutions Steal the Show in Bangkok When a company draws 59,468 attendees from over 150 countries, folks pay attention—and that was exactly the scene at Gastech 2026 in Bangkok. The name buzzing on many lips? Endurance Energy. These guys showcased a fresh take on energy logistics with their skid-mounted liquefaction tech, turning heads with their Southeast Asia...
Continue Reading
Spotlight on Geron's Corporate Governance: What's Happening? The heat's been turned up on Geron Corporation this week, with Halper Sadeh LLC, an investor rights law outfit, digging into whether some folks at the helm have strayed from their fiduciary duties to the shareholders. Now, if you're holding onto NASDAQ:GERN stock or thinking about diving in, it's high time to...
Continue Reading
What's Going On with AST SpaceMobile? Kicking off with a heavy hitter here, folks. AST SpaceMobile, Inc., trading under NASDAQ:ASTS, is under a securities fraud spotlight. We're talking allegations piled higher than a morning stack of pancakes. If you picked up any ASTS shares between March 4, 2025, and July 15, 2026, you're in on this rough ride. There's a class action...
Continue Reading
A Star-Studded Fantasy Comes Alive Hong Kong isn't just about dim sum and skyline views—it's a magnet for celebrity showcases, and this time, Jackson Wang's pulling the strings. The guy's ventured beyond music and idol fame, diving head-first into creative visuals with his fantasy IP, "Under the Castle" (UTC). Pairing up with Ocean Park's Halloween Fest, he's cooked up...
Continue Reading
Ah, sunglasses—the quintessential accessory that screams both practicality and style. A million-dollar look without the million-dollar expense? That's where Quay comes in. They've been recognized by Expert Consumers, no less, as some of the best-in-class for affordable luxury eye candy out there—aimed at shoppers who want the designer vibe without the hemorrhaging...
Continue Reading
Taking Flight with Legacy and Tradition Throwing a bash on Times Square isn't just about flash; it's about letting folks know you mean business. And China Southern Airlines has been doing just that for 70 years. Imagine starting from Guangzhou and ending up splashed across New York City's giant LED screens—talk about a journey! From Humble Roots to Global Network...
Continue Reading
Top 5 Most Recently Viewed Articles
BioLineRx Secures a Crucial Patent for Motixafortide BioLineRx Ltd. (NASDAQ:TASE: BLRX), a biopharmaceutical company dedicated to oncology and rare diseases, has made significant strides in its efforts to protect its innovative cancer drug, motixafortide. The company has received a Notice of Allowance from the U.S. Patent and Trademark Office, granting a new patent that...
Continue Reading
Global Ferulic Acid Market Outlook As the global market for ferulic acid continues to evolve, projections indicate a significant rise in value, moving from USD 207.7 million to USD 295.3 million in just a few years. By 2035, the market is expected to soar to USD 631.7 million, demonstrating a healthy compound annual growth rate (CAGR) of 7.9%. This growth can be...
Continue Reading
Key Factors Behind Hut 8 Corp's Rising Stock Value Recently, shares of Hut 8 Corp. (NASDAQ: HUT) have been experiencing a notable upward trend. This surge can be attributed to several significant factors that have captured the attention of investors and analysts alike. Positive Analyst Ratings Fueling Investor Confidence Analysts are currently revising their ratings and...
Continue Reading
Canada Nickel's Strategic Shuffle Somewhere along the line, you figure out what keeps the wheels turning in the resource game. For Canada Nickel, it looks like unloading some non-core baggage while doubling down on what really matters—the Crawford Nickel Project. On the chopping block is the Lucas Gold Project, now heading over to Noble Mineral Exploration. Meanwhile,...
Continue Reading
TotalEnergies Ventures into LNG and Renewable Expansion TotalEnergies SE (NYSE: TTE) has recently made headlines as its shares rise following the company's strategic presentation in New York, showcasing an ambitious outlook for the future. The focus on a disciplined investment policy indicates the company's commitment to navigating the evolving energy landscape. Ambitious...
Continue Reading